https://scholars.lib.ntu.edu.tw/handle/123456789/623271
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Teng, Wei | en_US |
dc.contributor.author | Chang, Ting-Tsung | en_US |
dc.contributor.author | Yang, Hwai-I | en_US |
dc.contributor.author | Peng, Cheng-Yuan | en_US |
dc.contributor.author | Su, Chien-Wei | en_US |
dc.contributor.author | TUNG-HUNG SU | en_US |
dc.contributor.author | Hu, Tsung-Hui | en_US |
dc.contributor.author | Yu, Ming-Lung | en_US |
dc.contributor.author | HUNG-CHIH YANG | en_US |
dc.contributor.author | Wu, Jaw-Ching | en_US |
dc.date.accessioned | 2022-09-29T08:57:29Z | - |
dc.date.available | 2022-09-29T08:57:29Z | - |
dc.date.issued | 2021-12 | - |
dc.identifier.issn | 1936-0533 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/623271 | - |
dc.description.abstract | ALT ≥ 80 U/L and HBV DNA ≥ 2000 IU/ml are treatment criteria of APASL guidelines for chronic hepatitis B (CHB) patients. The need of antiviral therapy for patients in gray zone (ALT < 80 U/L or HBV DNA < 2000 IU/ml) is controversial. This study aimed to develop a scoring system to predict hepatocellular carcinoma (HCC) and evaluate the benefit of antiviral therapy in these patients. | en_US |
dc.language.iso | en | en_US |
dc.publisher | SPRINGER | en_US |
dc.relation.ispartof | Hepatology international | en_US |
dc.subject | Antiviral therapy; Benefits; Family history; Gray zone; Hepatitis B virus; Hepatocellular carcinoma; Noncirrhosis; prediction; Risk score; Treatment guidelines | en_US |
dc.title | Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1007/s12072-021-10263-x | - |
dc.identifier.pmid | 34741723 | - |
dc.identifier.scopus | 2-s2.0-85118575810 | - |
dc.identifier.isi | WOS:000715018800001 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85118575810 | - |
dc.relation.pages | 1421 | en_US |
dc.relation.journalvolume | 15 | en_US |
dc.relation.journalissue | 6 | en_US |
dc.relation.pageend | 1430 | en_US |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Microbiology | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.orcid | 0000-0002-6747-7941 | - |
crisitem.author.orcid | 0000-0003-3864-9895 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。